Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Depressive Disorder, Major

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Depressive Disorder, Major in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegerl, U; Juckel, G; Karch, S; Koch, W; Mulert, C; Padberg, F; Pogarell, O; Segmiller, F; Tatsch, K1
Hegerl, U; Jakob, F; Koch, W; Möller, HJ; Mulert, C; Padberg, F; Pogarell, O; Pöpperl, G; Rupprecht, R; Tatsch, K; Zwanzger, P1
Grossheinrich, N; Hegerl, U; Jakob, F; Koch, W; Möller, HJ; Mulert, C; Padberg, F; Pogarell, O; Pöpperl, G; Rupprecht, R; Tatsch, K1
Chen, PS; Chiu, NT; Lee, IH; Lu, RB; Yang, YK; Yao, WJ; Yeh, TL1
Bockisch, A; Hahn, K; Hiemke, C; Nickel, O; Rao, ML; Schlegel, S; Schlösser, R1
Gaebel, W; Janz, A; Klimke, A; Larisch, R; Müller-Gärtner, HW; Vosberg, H1
Cooper, TB; Kegeles, LS; Laruelle, M; Mann, JJ; Oquendo, MA; Parsey, RV; Pratap, M; Rodenhiser, J; Van Heertum, R; Zea-Ponce, Y1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Depressive Disorder, Major

ArticleYear
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
    Journal of psychiatric research, 2006, Volume: 40, Issue:4

    Topics: Aged; Benzamides; Contrast Media; Depressive Disorder, Major; Dopamine; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Pilot Projects; Prefrontal Cortex; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Transcranial Magnetic Stimulation

2006

Other Studies

6 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Depressive Disorder, Major

ArticleYear
Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine.
    Psychiatry research, 2011, Dec-30, Volume: 194, Issue:3

    Topics: Aged; Benzamides; Brain Mapping; Corpus Striatum; Depressive Disorder, Major; Dopamine; Electroencephalography; Event-Related Potentials, P300; Female; Humans; Iodine Isotopes; Male; Middle Aged; Pyrrolidines; Statistics, Nonparametric; Time Factors; Tomography, Emission-Computed, Single-Photon; Transcranial Magnetic Stimulation

2011
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.
    Psychiatry research, 2007, Dec-15, Volume: 156, Issue:3

    Topics: Benzamides; Central Nervous System Stimulants; Corpus Striatum; Depressive Disorder, Major; Dextroamphetamine; Female; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Prefrontal Cortex; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Transcranial Magnetic Stimulation

2007
Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study.
    Psychiatry research, 2008, Apr-15, Volume: 162, Issue:3

    Topics: Adult; Benzamides; Depressive Disorder, Major; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Tomography, Emission-Computed, Single-Photon; Tropanes

2008
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Psychiatry research, 1997, Sep-29, Volume: 75, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benperidol; Benzamides; Bipolar Disorder; Brain; Clozapine; Corpus Striatum; Depressive Disorder, Major; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Frontal Lobe; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon

1997
Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.
    Psychiatry research, 1999, Apr-26, Volume: 90, Issue:2

    Topics: Adult; Aged; Anti-Anxiety Agents; Benzamides; Benzodiazepines; Case-Control Studies; Contrast Media; Corpus Striatum; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Pyrrolidines; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon

1999
Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.
    Biological psychiatry, 2001, Sep-01, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Amphetamine; Benzamides; Corpus Striatum; Depressive Disorder, Major; Dopamine; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2001